Cargando…
Nanostructured Lipid Carriers Made of Ω-3 Polyunsaturated Fatty Acids: In Vitro Evaluation of Emerging Nanocarriers to Treat Neurodegenerative Diseases
Neurodegenerative diseases (ND) are one of the main problems of public health systems in the 21st century. The rise of nanotechnology-based drug delivery systems (DDS) has become in an emerging approach to target and treat these disorders related to the central nervous system (CNS). Among others, th...
Autores principales: | Hernando, Sara, Herran, Enara, Hernandez, Rosa Maria, Igartua, Manoli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601928/ https://www.ncbi.nlm.nih.gov/pubmed/33003360 http://dx.doi.org/10.3390/pharmaceutics12100928 |
Ejemplares similares
-
ω-3 and ω-6 Polyunsaturated Fatty Acids, Obesity and Cancer
por: D’Angelo, Stefania, et al.
Publicado: (2020) -
ω-Alkynyl
Lipid Surrogates for Polyunsaturated
Fatty Acids: Free Radical and Enzymatic Oxidations
por: Beavers, William N., et al.
Publicado: (2014) -
Effect of ω-3 Polyunsaturated Fatty Acids-Derived Bioactive Lipids on Metabolic Disorders
por: Duan, Jinjie, et al.
Publicado: (2021) -
Implications of dietary ω-3 and ω-6 polyunsaturated fatty acids in breast cancer
por: Zanoaga, Oana, et al.
Publicado: (2018) -
Importance of the Role of ω-3 and ω-6 Polyunsaturated Fatty Acids in the Progression of Brain Cancer
por: Montecillo-Aguado, Mayra, et al.
Publicado: (2020)